Juan Monteverde, Partner at Faruqi & Faruqi, LLP is Seeking More Cash for the Shareholders of Theragenics Corporation (TGX)
Juan Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Theragenics Corporation (“Theragenics” or the “Company”) (NYSE: TGX) for potential breaches of fiduciary duties in connection with with the receipt of a going private proposal from Juniper Investment Company, LLC. Under the terms of the proposed transaction, Theragenics’ stockholders will receive between $2.25 and $2.30 for each share of Theragenics common stock they own, while Theragenics’ has a reported book value of $2.66 .
The investigation focuses on whether Theragenics’ Board of Directors breached their fiduciary duties to the Company’s stockholders by failing to conduct an adequate and fair sales process prior to agreeing to this proposed transaction, whether and by how much this proposed transaction undervalues the Company to the detriment of Theragenics’ shareholders.
If you own common stock in Theragenics and wish to obtain additional information and protect your investments free of charge, please contact Juan E. Monteverde, Esq. either via e-mail at email@example.com or by telephone at (877) 247-4292 or (212) 983-9330.
Please tell us about yourself by completing the form below and we will provide you with additional
information at no cost to you on how to join the Class Action.
* The submission of this form does not create an attorney-client relationship.
Juan E. Monteverde
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.